Vireo Growth (VREOF) Depreciation and Depletion (2020 - 2026)
Vireo Growth (VREOF) reported Depreciation and Depletion of $1.1 million for Q1 2026, up 1000.0% on a YoY basis from $100000.0 in Q1 2025, and down 89.34% sequentially from $10.3 million in Q4 2025.
Vireo Growth (VREOF) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Depreciation and Depletion data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 1000.0% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.4 million (up 3772.97% YoY), and the FY2025 full-year result was $11.3 million, up 3773.53% from the prior year.
- Depreciation and Depletion slipped to $1.1 million in Q1 2026, from $10.3 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $10.3 million in Q4 2025 to a low of $69931.0 in Q4 2024.
- A 5-year average of $816247.9 and a median of $156096.0 in 2022 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion slumped 53.89% in 2024 and surged 14657.85% in 2025, its largest moves.
- Tracing VREOF's Depreciation and Depletion over 5 years: stood at $165913.0 in 2022, then sank by 44.05% to $92827.0 in 2023, then fell by 24.67% to $69931.0 in 2024, then surged by 14657.85% to $10.3 million in 2025, then slumped by 89.34% to $1.1 million in 2026.
- Business Quant data shows VREOF's Depreciation and Depletion at $1.1 million in Q1 2026, $10.3 million in Q4 2025, and $552589.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.10 Mn |
| Dec 31, 2025 | 10.32 Mn |
| Dec 31, 2025 | 10.32 Mn |
| Sep 30, 2025 | 552,589.00 |
| Sep 30, 2025 | 552,589.00 |
| Jun 30, 2025 | 387,596.00 |
| Jun 30, 2025 | 387,596.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 69,931.00 |
| Dec 31, 2024 | 69,931.00 |
| Sep 30, 2024 | 76,292.00 |
| Sep 30, 2024 | 76,292.00 |
| Jun 30, 2024 | 72,925.00 |
| Jun 30, 2024 | 72,925.00 |
| Mar 31, 2024 | 73,547.00 |
| Mar 31, 2024 | 73,547.00 |
| Dec 31, 2023 | 92,827.00 |
| Dec 31, 2023 | 92,827.00 |